Serum albumin, genetic susceptibility, and risk of venous thromboembolism

被引:1
|
作者
Sun, Yuyang [1 ]
Deng, Jun [1 ]
Ding, Yajie [1 ]
Luo, Shanshan
Li, Si
Guan, Yunlong [2 ]
Cao, Xi [2 ]
Hao, Xingjie [2 ]
Hu, Yu [1 ]
机构
[1] Huazhong Univ Sci & Technol, Union Hosp, Inst Hematol, Tongji Med Coll, 1277,Jiefang Ave, Wuhan 430022, Hubei, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, 13 Hangkong Rd, Wuhan 430030, Hubei, Peoples R China
关键词
NEPHROTIC SYNDROME; THROMBOSIS; INFLAMMATION; ASSOCIATION; POPULATION; PREDICTORS; MORTALITY; EVENTS;
D O I
10.1016/j.rpth.2024.102509
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Previous research on the association between serum albumin (ALB) and venous thromboembolism (VTE) has produced inconclusive results. The polygenic risk score is constructed from a set of independent risk variants associated with a disorder, enabling the identification of a larger fraction of the population at comparable or greater disease risk. It is still unknown whether ALB and genetic factors jointly contribute to the incidence of VTE. Objectives: The present study aimed to explore ALB, genetic susceptibility, and the risk of VTE. Methods: The present investigation was an analysis of prospectively collected data from UK Biobank, a population-based, longitudinal cohort. Cox proportional models were used to calculate hazard ratios and 95% CIs for VTE. The Kaplan-Meier curve was utilized to visualize the cumulative risk of VTE according to different serum ALB levels, and the restricted cubic spline model was leveraged to explore the exposure-response relationship among ALB levels and VTE risk. Results: During median follow-up of 13.5 years, 11,502 cases with VTE were diagnosed among 417,113 participants in the UK Biobank. The lower ALB levels were associated with a higher risk for VTE. Individuals with both a high genetic risk and lowest ALB level had the highest risk of VTE (hazard ratio, 3.89; 95% CI, 3.41-4.43), compared with those with low genetic risk and highest ALB level. The positive joint effects of low ALB and polygenic risk score increased the risk of VTE in individuals with high genetic risk. This study excluded non-European patients and primarily focused on the European population, which may limit the generalizability of the findings. Conclusion: Low serum ALB levels were linked to an increased risk of VTE, which was in accordance with a linear dose-response relationship. There was a positive additive effect of ALB and genetic susceptibility on the risk of VTE. ALB could serve as a biomarker for predicting the risk of VTE.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Serum albumin and risk of venous thromboembolism
    Folsom, Aaron R.
    Lutsey, Pamela L.
    Heckbert, Susan R.
    Cushman, Mary
    THROMBOSIS AND HAEMOSTASIS, 2010, 104 (01) : 100 - 104
  • [2] Genetic susceptibility, smoking, obesity and risk of venous thromboembolism
    Severinsen, Marianne T.
    Overvad, Kim
    Johnsen, Soren P.
    Dethlefsen, Claus
    Madsen, Poul H.
    Tjonneland, Anne
    Kristensen, Soren R.
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 149 (02) : 273 - 279
  • [3] Serum Albumin and Circulating Metabolites and Risk of Venous Thromboembolism: A Two-Sample Mendelian Randomization Study
    Liu, Zhengye
    Mi, Jiarui
    FRONTIERS IN NUTRITION, 2021, 8
  • [4] Inverse association between serum albumin and future risk of venous thromboembolism: interrelationship with high sensitivity C-reactive protein
    Kunutsor, Setor K.
    Seidu, Samuel
    Katechia, Devvrat T.
    Laukkanen, Jari A.
    ANNALS OF MEDICINE, 2018, 50 (03) : 240 - 248
  • [5] Microalbuminuria and Risk of Venous Thromboembolism
    Mahmoodi, Bakhtawar K.
    Gansevoort, Ron T.
    Veeger, Nic J. G. M.
    Matthews, Abigail G.
    Navis, Gerjan
    Hillege, Hans L.
    van der Meer, Jan
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (17): : 1790 - 1797
  • [6] Chemotherapy, Genetic Susceptibility, and Risk of Venous Thromboembolism in Breast Cancer Patients
    Brand, Judith S.
    Hedayati, Elham
    Humphreys, Keith
    Ludvigsson, Jonas F.
    Johansson, Anna L. V.
    Bergh, Jonas
    Hall, Per
    Czene, Kamila
    CLINICAL CANCER RESEARCH, 2016, 22 (21) : 5249 - 5255
  • [7] Association Between Decreased Serum Albumin With Risk of Venous Thromboembolism and Mortality in Cancer Patients
    Koenigsbruegge, Oliver
    Posch, Florian
    Riedl, Julia
    Reitter, Eva-Maria
    Zielinski, Christoph
    Pabinger, Ingrid
    Ay, Cihan
    ONCOLOGIST, 2016, 21 (02) : 252 - 257
  • [8] Serum uric acid, gout, and venous thromboembolism: The atherosclerosis risk in communities study
    Kubota, Yasuhiko
    McAdams-DeMarco, Mara
    Folsom, Aaron R.
    THROMBOSIS RESEARCH, 2016, 144 : 144 - 148
  • [9] Albumin, oral contraceptives, and venous thromboembolism risk in astronauts
    Zwart, Sara R.
    Aunon-Chancellor, Serena M.
    Heer, Martina
    Melin, M. Mark
    Smith, Scott M.
    JOURNAL OF APPLIED PHYSIOLOGY, 2022, 132 (05) : 1232 - 1239
  • [10] Serum uric acid levels and the risk of recurrent venous thromboembolism
    De Lucchi, Lara
    Nardin, Chiara
    Sponchiado, Alessandra
    Raggi, Davide
    Faggin, Elisabetta
    Martini, Elena
    Pagliara, Valeria
    Callegari, Elena
    Caberlotto, Livio
    Plebani, Mario
    Pauletto, Paolo
    Cinetto, Francesco
    Agostini, Carlo
    Villalta, Sabina
    Rattazzi, Marcello
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2021, 19 (01) : 194 - 201